Herman A E, Tisch R M, Patel S D, Parry S L, Olson J, Noble J A, Cope A P, Cox B, Congia M, McDevitt2 H O
Program in Immunology, Departments of Microbiology and Immunology, Pediatrics, and Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
J Immunol. 1999 Dec 1;163(11):6275-82.
Particular HLA class II allelic sequences are associated with susceptibility to type I diabetes. To understand the mechanism, knowledge of the molecular nature of the specific TCR/peptide/class II interactions involved in the disease process is required. To this end, we have introduced the diabetes-associated human class II HLA-DQ8 allele (DQA10301/DQB10302) as a transgene into mice and analyzed T cell responses restricted by this molecule to an important Ag in human diabetes, human glutamic acid decarboxylase 65. Hybridomas were used to determine the particular peptides from this Ag presented by HLA-DQ8 to T cells and to map the core minimal epitopes required for T cell stimulation. Analysis of these core epitopes reveals a motif and relevant features for peptides that are immunogenic to T cells when presented by HLA-DQ8. The major immunogenic epitopes of glutamic acid decarboxylase 65 do not contain a negatively charged residue that binds in the P9 pocket of the HLA-DQ8 molecule. PBMC from HLA-DQ8+ diabetic and nondiabetic individuals respond to these peptides, confirming that the mouse model is a useful tool to define epitopes of autoantigens that are processed by human APC and recognized by human T cells.
特定的人类白细胞抗原(HLA)II类等位基因序列与I型糖尿病易感性相关。为了解其机制,需要知晓疾病过程中所涉及的特定T细胞受体(TCR)/肽段/HLA II类分子相互作用的分子本质。为此,我们已将与糖尿病相关的人类HLA II类DQ8等位基因(DQA10301/DQB10302)作为转基因导入小鼠,并分析了受该分子限制的针对人类糖尿病中一种重要抗原——人谷氨酸脱羧酶65(GAD65)的T细胞应答。利用杂交瘤来确定HLA-DQ8呈递给T细胞的该抗原的特定肽段,并定位T细胞刺激所需的核心最小表位。对这些核心表位的分析揭示了由HLA-DQ8呈递时对T细胞具有免疫原性的肽段的基序和相关特征。谷氨酸脱羧酶65的主要免疫原性表位不包含在HLA-DQ8分子P9口袋中结合的带负电荷残基。来自HLA-DQ8阳性糖尿病个体和非糖尿病个体的外周血单核细胞(PBMC)对这些肽段有反应,证实该小鼠模型是定义由人类抗原呈递细胞(APC)加工并被人类T细胞识别的自身抗原表位的有用工具。